Cancer Chemotherapy and Pharmacology

, Volume 58, Issue 6, pp 835–837 | Cite as

Panmucositis and chemosensitisation associated with betel quid chewing during dose-dense adjuvant breast cancer chemotherapy

  • Richard J. Epstein
  • Thomas W. T. Leung
  • Polly S. Y. Cheung
Short Communication
  • 65 Downloads

Abstract

Purpose: The severity of chemotherapy-induced oral mucositis has previously been reported to be greater in patients who chew betel quid (areca), an addictive habit shared by hundreds of millions of individuals worldwide. Here, we report a case of fulminant panmucositis complicating dose-dense adjuvant breast cancer treatment in a betel-chewing patient without evidence of other risk factors. Methods: Grade IV mucositis was triggered by the initial use of standard-dose anthracycline chemotherapy, and involved not only the mouth but also the genital and anal mucosa, as well as other severe non-mucosal toxicities. Results: Despite subsequent treatment with dose-reduced CMF and docetaxel regimens—which are seldom associated with mucosal toxicity at these dose intensities in the absence of neutropenia—high-grade oral mucositis continued to complicate the therapeutic course. Conclusion: These observations suggest that the potentiation of chemotherapy-induced mucositis by quid chewing may not be mediated solely by local effects on the oral epithelium, but also involves the systemic absorption of toxic chemosensitising molecules.

Keywords

Cytotoxic drug treatment Iatrogenic toxicity Areca 

Notes

Acknowledgment

We thank Miranda Ho for secretarial assistance.

References

  1. 1.
    Pickwell SM, Schimelpfening S, Palinkas LA (1994) ‘Betelmania’. Betel quid chewing by Cambodian women in the United States and its potential health effects. West J Med 160(4):326–330PubMedGoogle Scholar
  2. 2.
    Warnakulasuriya S, Sutherland G, Scully C (2005) Tobacco, oral cancer, and treatment of dependence. Oral Oncol 41(3):244–260PubMedCrossRefGoogle Scholar
  3. 3.
    Strickland SS et al (2003) Areca nut, energy metabolism and hunger in Asian men. Ann Hum Biol 30(1):26–52PubMedCrossRefGoogle Scholar
  4. 4.
    Chu NS (2001) Effects of betel chewing on the central and autonomic nervous systems. J Biomed Sci 8(3):229–236PubMedCrossRefGoogle Scholar
  5. 5.
    Videtic GM et al (2003) Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 21(8):1544–1599PubMedCrossRefGoogle Scholar
  6. 6.
    Browman GP et al (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328(3):159–163PubMedCrossRefGoogle Scholar
  7. 7.
    Sadasivan G, Rani G, Kumari CK (1978) Chromosome-damaging effect of betel leaf. Mutat Res 57(2):183–185PubMedGoogle Scholar
  8. 8.
    Lee HC et al (2001) Accumulation of mitochondrial DNA deletions in human oral tissues—effects of betel quid chewing and oral cancer. Mutat Res 493(1–2):67–74PubMedGoogle Scholar
  9. 9.
    Ghosh PK, Ghosh R (1988) Effect of betel chewing on the frequency of sister chromatid exchanges in pregnant women and women using oral contraceptives. Cancer Genet Cytogenet 32(2):211–215PubMedCrossRefGoogle Scholar
  10. 10.
    Zienolddiny S et al (2004) Genomic instability in oral squamous cell carcinoma: relationship to betel-quid chewing. Oral Oncol 40(3):298–303PubMedCrossRefGoogle Scholar
  11. 11.
    Lee JJ et al (2005) Univariate and multivariate analysis of prognostic significance of betel quid chewing in squamous cell carcinoma of buccal mucosa in Taiwan. J Surg Oncol 91(1):41–47PubMedCrossRefGoogle Scholar
  12. 12.
    Jeng JH et al. (1994) Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res 73(5):1043–1049PubMedGoogle Scholar
  13. 13.
    Lin SC et al (2005) Areca (betel) nut extract activates mitogen-activated protein kinasesand NF-kappaB in oral keratinocytes. Int J Cancer 116(4):526–535PubMedCrossRefGoogle Scholar
  14. 14.
    Haque MF et al (2000) Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med 29(3):123–128PubMedCrossRefGoogle Scholar
  15. 15.
    Tsai CH et al (2005) Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro. J Oral Pathol Med 34(2):100–105PubMedCrossRefGoogle Scholar
  16. 16.
    Wang HM et al (1999) Impact of oral submucous fibrosis on chemotherapy-induced mucositis for head and neck cancer in a geographic area in which betel quid chewing is prevalent. Am J Clin Oncol 22(5):485–488PubMedCrossRefGoogle Scholar
  17. 17.
    Chiu CJ et al (2002) A scoring system for the early detection of oral submucous fibrosis based on a self-administered questionnaire. J Public Health Dent 62(1):28–31PubMedCrossRefGoogle Scholar
  18. 18.
    McCarthy GM et al (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34(6):484–490PubMedCrossRefGoogle Scholar
  19. 19.
    Porock D, Nikoletti S, Cameron F (2004) The relationship between factors that impair wound healing and the severity of acute radiation skin and mucosal toxicities in head and neck cancer. Cancer Nurs 27(1):71–78PubMedCrossRefGoogle Scholar
  20. 20.
    Liu TY et al (2004) Safrole-DNA adducts in human peripheral blood—an association with areca quid chewing and CYP2E1 polymorphisms. Mutat Res 559(1–2):59–66PubMedGoogle Scholar
  21. 21.
    Desai SS et al (1996) Cytogenetic damage in exfoliated oral mucosal cells and circulating lymphocytes of patients suffering from precancerous oral lesions. Cancer Lett 109(1–2):9–14PubMedCrossRefGoogle Scholar
  22. 22.
    Keefe DM et al (2000) Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47(5):632–637PubMedCrossRefGoogle Scholar
  23. 23.
    Kitani H et al (1990) The “recall effect” in radiotherapy: is subeffective, reparable damage involved? Int J Radiat Oncol Biol Phys 18(3):689–695PubMedGoogle Scholar
  24. 24.
    Yeo W, Johnson PJ (2000) Radiation-recall skin disorders associated with the use of antineoplastic drugs. Pathogenesis, prevalence, and management. Am J Clin Dermatol 1(2):113–116PubMedCrossRefGoogle Scholar
  25. 25.
    Gabel C et al (1995) Radiation recall reaction to idarubicin resulting in vaginal necrosis. Gynecol Oncol 57(2):266–269PubMedCrossRefGoogle Scholar
  26. 26.
    Stich HF et al (1991) Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenance of the protective effect of beta-carotene or vitamin A. Am J Clin Nutr 53(1 Suppl):298S-304SPubMedGoogle Scholar
  27. 27.
    Mantovani G et al (2003) Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs. Oncol Rep 10(1):197–206PubMedGoogle Scholar
  28. 28.
    Farrell CL et al (2002) The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 35(Suppl 1):78–85PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Richard J. Epstein
    • 1
    • 2
  • Thomas W. T. Leung
    • 2
  • Polly S. Y. Cheung
    • 3
  1. 1.Division of Haematology/Oncology, Department of MedicineUniversity of Hong KongPokfulamHong Kong
  2. 2.Comprehensive Oncology CentreHong Kong Sanatorium & HospitalHappy ValleyHong Kong
  3. 3.Breast Care CentreHong Kong Sanatorium & HospitalHappy ValleyHong Kong

Personalised recommendations